Cargando…
Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022)
BACKGROUND: Coronavirus disease (COVID‐19), an infectious disease caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Managem...
Autores principales: | Yamakawa, Kazuma, Yamamoto, Ryo, Terayama, Takero, Hashimoto, Hideki, Ishihara, Tadashi, Ishimaru, Go, Imura, Haruki, Okano, Hiromu, Narita, Chihiro, Mayumi, Takuya, Yasuda, Hideto, Yamada, Kohei, Yamada, Hiroyuki, Kawasaki, Tatsuya, Shime, Nobuaki, Doi, Kent, Egi, Moritoki, Ogura, Hiroshi, Aihara, Morio, Kushimoto, Shigeki, Nishida, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579991/ https://www.ncbi.nlm.nih.gov/pubmed/36267628 http://dx.doi.org/10.1002/ams2.789 |
Ejemplares similares
-
Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)
por: Yamakawa, Kazuma, et al.
Publicado: (2021) -
Japanese rapid/living recommendations on drug management for COVID‐19
por: Yamakawa, Kazuma, et al.
Publicado: (2021) -
ARDS Clinical Practice Guideline 2021
por: Tasaka, Sadatomo, et al.
Publicado: (2022) -
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016)
por: Nishida, Osamu, et al.
Publicado: (2018) -
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)
por: Nishida, Osamu, et al.
Publicado: (2018)